Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
4.120
-0.310 (-7.00%)
Jun 5, 2026, 1:24 PM EDT - Market open
Cybin Market Cap
Cybin has a market cap or net worth of $206.15 million as of June 5, 2026. Its market cap has increased by 30.66% in one year.
Market Cap
206.15M
Enterprise Value
26.53M
1-Year Change
30.66%
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $206.15M, an increase of 126.30%. That is a compound annual growth rate of 15.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 215.15M | -47.29% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LENZ Therapeutics | 219.79M |
| Minerva Neurosciences | 218.04M |
| Voyager Therapeutics | 217.52M |
| Camp4 Therapeutics | 216.53M |
| Arcturus Therapeutics Holdings | 216.02M |
| Fulcrum Therapeutics | 214.56M |
| Whitehawk Therapeutics | 214.52M |
| Foghorn Therapeutics | 213.72M |